Literature DB >> 8719805

Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats.

L A Dawson1, C Routledge.   

Abstract

1. The selective Ca(2+)-activated K+ channel blocker apamin increased extracellular 5-hydroxytryptamine (5-HT) concentrations in the striatum when administered through the microdialysis probe at doses of 0.1 mM and 1 mM. Extracellular dopamine concentrations increased only at the highest dose administered (1 mM). 2. Mast cell degranulating peptide (MCDP), which blocks the dendrotoxin sensitive delayed rectifier (DR) current, increased extracellular concentrations of dopamine at dose of 10 microM-100 microM but had no effect on 5-HT. 3. The non selective K+ channel blocker tetraethylammonium (TEA) induced a dose-dependent (1 mM-10 mM) increase in extracellular dopamine concentrations and an increase in 5-HT which showed little or no dose-dependency. 4. 4-Aminopyridine (4-AP), a blocker with some similar characteristics to MCDP, increased extracellular dopamine concentrations at doses of 10 microM-1 mM, but had no effect on 5-HT. 5. These findings suggest that dopamine release may be modulated by DR-like current and/or A-current K+ channels. However, in view of the similar effects of MCDP and 4-AP at the concentrations used it is more likely that the dendrotoxin-sensitive DR-like current is involved. In contrast, 5-HT release appears to be modulated by Ca(2+)-activated K+ channels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719805      PMCID: PMC1909189          DOI: 10.1111/j.1476-5381.1995.tb15133.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Effects of the potassium channel blocking dendrotoxins on acetylcholine release and motor nerve terminal activity.

Authors:  A J Anderson; A L Harvey
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

Review 2.  Diversity and ubiquity of K channels.

Authors:  B Rudy
Journal:  Neuroscience       Date:  1988-06       Impact factor: 3.590

3.  Temporal integration by a slowly inactivating K+ current in hippocampal neurons.

Authors:  J F Storm
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

Review 4.  An animal behavior model for studying central serotonergic synapses.

Authors:  B L Jacobs
Journal:  Life Sci       Date:  1976-09-15       Impact factor: 5.037

Review 5.  Apamin.

Authors:  E Habermann
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

6.  Dendrotoxin from the venom of the green mamba, Dendroaspis angusticeps. A neurotoxin that enhances acetylcholine release at neuromuscular junction.

Authors:  A L Harvey; E Karlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

7.  Effect of calcium on synaptic facilitation by potassium channel blockers in superior cervical ganglion of rat.

Authors:  K A Alkadhi; Y H Hogan
Journal:  Neuropharmacology       Date:  1989-01       Impact factor: 5.250

8.  5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration.

Authors:  Q Pei; R A Leslie; D G Grahame-Smith; T S Zetterström
Journal:  Neuroreport       Date:  1995-03-27       Impact factor: 1.837

9.  Differential effects of 4-aminopyridine and 2,4-diaminopyridine on the in vivo release of acetylcholine and dopamine in freely moving rats measured by intrastriatal dialysis.

Authors:  G Damsma; P T Biessels; B H Westerink; J B De Vries; A S Horn
Journal:  Eur J Pharmacol       Date:  1988-01-05       Impact factor: 4.432

10.  Inhibitory effect of 1,2,3,4-tetrahydro-9-aminoacridine on the depolarization-induced release of GABA from cerebral cortex.

Authors:  J de Belleroche; I M Gardiner
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

View more
  6 in total

1.  4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels.

Authors:  Renato Pirisino; Nicoletta Galeotti; Silvia Livi; Laura Raimondi; Carla Ghelardini
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

2.  Methylamine-dependent release of nitric oxide and dopamine in the CNS modulates food intake in fasting rats.

Authors:  L Raimondi; C Alfarano; A Pacini; S Livi; C Ghelardini; G DeSiena; R Pirisino
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

3.  Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study.

Authors:  L A Dawson; H Q Nguyen; D I Smith; L E Schechter
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Glibenclamide alters serotonin and dopamine levels in the rat striatum and hippocampus, reducing cognitive impairment.

Authors:  Alexander S Zubov; Irina S Ivleva; Nina S Pestereva; Tatiana V Tiutiunnik; Dmitrtii S Traktirov; Marina N Karpenko
Journal:  Psychopharmacology (Berl)       Date:  2022-05-11       Impact factor: 4.415

5.  Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels.

Authors:  R Pirisino; C Ghelardini; G Banchelli; N Galeotti; L Raimondi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status.

Authors:  Elmira Anderzhanova; Mihai Covasa; Andras Hajnal
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-06       Impact factor: 3.619

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.